86 related articles for article (PubMed ID: 9540040)
1. Different effects of acarbose and voglibose on serum 1,5-anhydroglucitol concentrations.
Sakane N; Yoshida T; Kogure A; Kondo M
Diabetes Care; 1998 Mar; 21(3):465-6. PubMed ID: 9540040
[No Abstract] [Full Text] [Related]
2. Comparison of the effects of acarbose and voglibose in healthy subjects.
Kageyama S; Nakamichi N; Sekino H; Nakano S
Clin Ther; 1997; 19(4):720-9. PubMed ID: 9377616
[TBL] [Abstract][Full Text] [Related]
3. Different effects of two alpha-glucosidase inhibitors, acarbose and voglibose, on serum 1,5-anhydroglucitol (1,5AG) level.
Watanabe K; Uchino H; Ohmura C; Tanaka Y; Onuma T; Kawamori R
J Diabetes Complications; 2004; 18(3):183-6. PubMed ID: 15145332
[TBL] [Abstract][Full Text] [Related]
4. Rapid improvement of serum 1,5-anhydroglucitol concentrations after administration of alpha-glucosidase inhibitor.
Yoshioka K; Azukari K; Yoshida T; Kondo M
Diabetes Care; 1997 Mar; 20(3):462. PubMed ID: 9051408
[No Abstract] [Full Text] [Related]
5. [Oral hypoglycemic agents--overview].
Sakamoto N; Uno T
Nihon Rinsho; 1997 Nov; 55 Suppl():94-8. PubMed ID: 9434450
[No Abstract] [Full Text] [Related]
6. [alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action].
Odaka H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():393-8. PubMed ID: 12387024
[No Abstract] [Full Text] [Related]
7. Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
Nagai Y; Hayakawa T; Abe T; Nomura G
Diabetes Care; 2000 Nov; 23(11):1703. PubMed ID: 11092296
[No Abstract] [Full Text] [Related]
8. Impairment of absorption of digoxin by acarbose.
Miura T; Ueno K; Tanaka K; Sugiura Y; Mizutani M; Takatsu F; Takano Y; Shibakawa M
J Clin Pharmacol; 1998 Jul; 38(7):654-7. PubMed ID: 9702852
[TBL] [Abstract][Full Text] [Related]
9. Effect of seven inhibitors on invertases in homogenates of human dental plaque.
Fiehn NE; Moe D
Scand J Dent Res; 1983 Jun; 91(3):175-81. PubMed ID: 6224287
[TBL] [Abstract][Full Text] [Related]
10. Voglibose has no effect on the pharmacokinetics of hydrochlorothiazide.
Kleist P; Suzuki Y; Thomsen T; Möller M; Römer A; Hucke HP; Kurowski M; Eckl KM
Eur J Clin Pharmacol; 1998 May; 54(3):273-4. PubMed ID: 9681672
[No Abstract] [Full Text] [Related]
11. Comparisons of Effects on Intestinal Short-Chain Fatty Acid Concentration after Exposure of Two Glycosidase Inhibitors in Mice.
Xu GD; Cai L; Ni YS; Tian SY; Lu YQ; Wang LN; Chen LL; Ma WY; Deng SP
Biol Pharm Bull; 2018; 41(7):1024-1033. PubMed ID: 29962399
[TBL] [Abstract][Full Text] [Related]
12. Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors.
Chen X; Zheng Y; Shen Y
Curr Med Chem; 2006; 13(1):109-16. PubMed ID: 16457643
[TBL] [Abstract][Full Text] [Related]
13. [Alpha-glucosidase inhibitor and insulin sensitizer combination therapy in NIDDM].
Kitaoka H
Nihon Rinsho; 1997 Nov; 55 Suppl():192-6. PubMed ID: 9434466
[No Abstract] [Full Text] [Related]
14. Intestinal alpha-glucosidase inhibitors: abdominal gas cysts.
Prescrire Int; 2012 Sep; 21(130):212-3. PubMed ID: 23016254
[TBL] [Abstract][Full Text] [Related]
15. Alpha-glucosidase inhibition assay in an enzyme-immobilized amino-microplate.
Matsui T; Shimada M; Saito N; Matsumoto K
Anal Sci; 2009 Apr; 25(4):559-62. PubMed ID: 19359799
[TBL] [Abstract][Full Text] [Related]
16. [Alpha-glucosidase inhibitors of microbial origin].
Selezneva AA; Akulova NIu
Nauchnye Doki Vyss Shkoly Biol Nauki; 1992; (2):25-32. PubMed ID: 1302499
[TBL] [Abstract][Full Text] [Related]
17. Three diabetic cases of acute dizziness due to initial administration of voglibose.
Bando Y; Ushiogi Y; Toya D; Tanaka N; Fujisawa M
Intern Med; 1998 Sep; 37(9):753-6. PubMed ID: 9804082
[TBL] [Abstract][Full Text] [Related]
18. [Voglibose].
Hara T; Hotta N
Nihon Rinsho; 1997 Nov; 55 Suppl():114-9. PubMed ID: 9434453
[No Abstract] [Full Text] [Related]
19. Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy.
Hotta N; Koh N; Sakakibara F; Naruse K; Yamada T; Takeuchi N; Yamada K; Fukasawa H; Kakuta H
Biomed Pharmacother; 1996; 50(6-7):297-302. PubMed ID: 8952871
[TBL] [Abstract][Full Text] [Related]
20. [Measures to meet the side effects of the orally administered antihyperglycemic drugs].
Ishii J; Inoue I
Nihon Rinsho; 1997 Nov; 55 Suppl():104-13. PubMed ID: 9434452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
